Status:
COMPLETED
Selenium Supplementation of Patients With Cirrhosis
Lead Sponsor:
Vanderbilt University
Collaborating Sponsors:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions:
Healthy
Liver Cirrhosis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to determine whether patients with liver disease can improve their nutritional selenium status by taking supplemental selenium.
Detailed Description
Selenium is an essential nutrient. Selenium carries out its biological functions through selenoproteins. The most abundant selenoprotein in the plasma is selenoprotein P, which is largely synthesized ...
Eligibility Criteria
Inclusion
- Healthy Adults
- Adults with Child-Pugh Class C liver cirrhosis
Exclusion
- Diagnosis of renal failure
- Urgent need of liver transplant
- Selenium supplements of \>25 µg per day during the past year
Key Trial Info
Start Date :
October 1 1998
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2003
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT00212186
Start Date
October 1 1998
End Date
November 1 2003
Last Update
March 7 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vanderbilt University Medical Center
Nashville, Tennessee, United States, 37232